Episode Details

Dobutamine is a direct-acting parenteral sympathomimetic inotrope. It primarily acts as an agonist at beta1-adrenergic receptors (with minor beta2 and alpha1 stimulatory effects) to increase myocardial contractility, stroke volume, and cardiac output. Unlike dopamine, it does not stimulate dopaminergic receptors or release norepinephrine. It has comparatively mild chronotropic, hypertensive, arrhythmogenic, and vasodilative effects, and minimally affects pulmonary vascular resistance.

Primary Indications & Clinical Dosing:

• Low Output States: Used for short-term treatment of cardiac decompensation due to depressed contractility from organic heart disease, cardiac surgery, congestive heart failure, cardiogenic shock, or septic shock.
• Continuous IV Dosage: Initiate adults, children, and neonates at 0.5 to 1 mcg/kg/min, titrating to a usual dose of 2 to 20 mcg/kg/min based on response. Rates >20 mcg/kg/min may cause tachycardia or ectopy; 40 mcg/kg/min is rarely required.
• Diagnostics: Used in dobutamine stress echocardiography starting at 5 mcg/kg/min, titrating up to 40 mcg/kg/min.
• Special Populations: No dose adjustments are needed for renal or hepatic impairment.

Critical Administration Rules:

• Dilution & Infusion: Must be diluted before use (maximum concentration 5,000 mcg/mL; standard adult concentration is 4,000 mcg/mL). Infuse using a controlled device, preferably into a large vein.
• Incompatibilities: Incompatible with sodium bicarbonate or strong alkaline solutions. Do not infuse dextrose-containing dobutamine through the same line as blood due to risk of pseudoagglutination/hemolysis.
• Physical Stability: Premixed bags in 5% Dextrose may turn pink over time due to slight oxidation, which does not impact potency.
• Intraosseous (IO): Not FDA-approved, but the same dose can be given via IO route during CPR if IV access is unfeasible.

Pharmacokinetics & Safety Profile:

• Rapid Action: Infused intravenously, it has an onset of 2 minutes and a half-life of ~2 minutes.
• Severe Adverse Reactions: Can cause ventricular tachycardia, arrhythmia exacerbation, pulmonary edema, skin necrosis, and anaphylactoid reactions.
• Moderate Reactions: Includes hypertension, angina, palpitations, dyspnea, and premature ventricular contractions. Dosage titration must be guided closely by systemic blood pressure, heart rate, urine flow, and ectopic activity.